COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. (2022)

First Author: Alexander JL
Attributed to:  King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(22)00005-x

PubMed Identifier: 35123676

Publication URI: http://europepmc.org/abstract/MED/35123676

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Gastroenterology & hepatology

Issue: 4